Evidence map›Paper›PMID 37638060›Full record

ArticleAnalytical cellular pathology (Amsterdam)2023

Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells.

Wenjia Ren, Cheng Yue, Linjun Liu, Licheng Du, Ke Xu, Yubai Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical cellular pathology (Amsterdam), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wenjia RenDepartment of Biotechnology, College of Life Science and Chemistry, Beijing University of Technology, Chaoyang, Beijing, China.ORCID https://orcid.org/0009-0005-6618-6607
Cheng YueDepartment of Biotechnology, College of Life Science and Chemistry, Beijing University of Technology, Chaoyang, Beijing, China.
Linjun LiuDepartment of Biotechnology, College of Life Science and Chemistry, Beijing University of Technology, Chaoyang, Beijing, China.
Licheng DuDepartment of Biotechnology, College of Life Science and Chemistry, Beijing University of Technology, Chaoyang, Beijing, China.
Ke XuNHC Key Laboratory of biosafety, National Institute for Viral Disease Control and Prevention, Changping, Beijing, China.ORCID https://orcid.org/0009-0002-4790-1300
Yubai ZhouDepartment of Biotechnology, College of Life Science and Chemistry, Beijing University of Technology, Chaoyang, Beijing, China.ORCID https://orcid.org/0000-0003-1066-7071
Beijing University of Technology · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the most lethal malignant tumors in the world. Non-small cell lung cancer (NSCLC) is the most common pathological subtype. However, the molecular mechanism of NSCLC progress is still unclear. We extracted the expression data of the Bruton's tyrosine kinase (

Indexed as

Agammaglobulinaemia Tyrosine KinaseCarcinoma, Non-Small-Cell LungLung NeoplasmsBlotting, WesternCell ProliferationHumansAgammaglobulinaemia Tyrosine KinaseBTK protein, human

Identifiers

PMID37638060
PMCPMC10457169
OpenAlexW4385971005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.